Bacteraemia with an MBL-producing Klebsiella pneumoniae : treatment and the potential role of cefiderocol heteroresistance

Abstract excerpt

Infections with carbapenem-resistant Enterobacterales (CRE) are associated with mortality rates of up to 50% in the USA.1 Optimal empirical treatment remains challenging and requires collaboration between microbiologists, clinicians and sometimes translational researchers as traditional susceptibility testing methods may fail to detect clinically meaningful resistance. Here we describe a patient with Klebsiella...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibiotic Resistance in Bacteria
• Share to Antibiotics Pharmacokinetics and Efficacy
• Share to Bacterial Identification and Susceptibility Testing